Toronto, April 3, 2014 - Dr. Etienne Sibille, an expert on the brain science of
depression, is joining the Centre for Addiction and Mental Health (CAMH) and the
University of Toronto as inaugural Campbell Family Chair
in Clinical Neuroscience.
Dr. Sibille seeks to understand the molecular changes in the
brain associated with depression, and with aging and the development of mental
illnesses. By using different approaches that combine studies of human brain
tissue along with genetics and pre-clinical models, he has generated new hypotheses
and experimental approaches to studying the development of disease.
Dr. Sibille was recruited from the University of Pittsburgh’s
Department of Psychiatry, where he was associate professor. His lab will be
based in CAMH’s Campbell Family Mental Health Research Institute.
“Dr. Sibille’s highly innovative approaches are already
paving the way to make substantial progress in understanding and finding new treatments
for depression,” says Dr. Bruce G. Pollock, Vice President of Research and
Director of the Campbell Family Mental Health Research Institute at CAMH. “As a
productive scientist and dedicated mentor, his leadership is a valuable
addition to the Toronto
Depression is the leading cause of disability worldwide, and
current front-line treatments only work for perhaps 50 per cent of individuals.
“Neuropsychiatric disorders in general, and depression in
particular, are complex system disorders, yet their mechanisms can be tracked
back to brain circuit and cellular dysfunctions,” says Dr. Sibille. “The
characterization of this primary pathology is the first step towards the
development of new therapeutic strategies and drugs. CAMH provides the ideal
environment to foster interactions and promote multi-disciplinary projects. I
am very excited and truly honored to join such an exceptional scientific
Dr. Sibille is an award-winning scientist with more than 70
peer-reviewed publications. Notably, he received the U.S. National Institute of
Mental Health Independent Scientist Award in 2009. He also serves as a reviewer
for leading psychiatric journals, including Molecular Psychiatry, the American
Journal of Psychiatry, Biological Psychiatry and Neuropsychopharmacology.
Dr. Sibille earned a PhD in Pharmacology from Cornell University
in 1999, and completed a postdoctoral fellowship at Columbia University
with Dr. René Hen at the Center for Neurobiology and Behavior.
Media contact: Kate Richards, CAMH Media Relations,
416-595-6015; or by email at email@example.com
The Centre for Addiction and Mental Health (CAMH) is Canada's
largest mental health and addiction teaching hospital, and one of the world's
leading research centres in its field. CAMH combines clinical care, research,
education, policy development and health promotion to help transform the lives
of people affected by mental health and addiction issues. CAMH is fully
affiliated with the University
of Toronto, and is a Pan
American Health Organization/World Health Organization Collaborating Centre.
For more information, please visit www.camh.ca.